|
(±)-threo-Ritalinic acid-D10
|
R-027
|
1.0 mg/mL (as free base) in Methanol
Ritalinic acid is the major urinary metabolite of methylphenidate, more commonly known by the brand name Ritalin, which is approved for treatment of ADHD (Attention-Deficit Hyperactivity Disorder) and narcolepsy. This new stable-labeled internal standard is suitable for a wide variety of GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods.
|
|
|